Zealand Pharma Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Copenhagen Denmark (1998)

Organization Overview

First Clinical Trial
2006
NCT00283361
First Marketed Drug
2001
lixisenatide (adlyxin)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Zealand Pharma | ZEALAND PHARMA | Zealand Pharma A/S